Clinical Trial Update: Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry [Phase 3]

View source ↗

Summary

This document provides an update on the IDEAL-PCI registry, a Phase 3 study investigating how to individualize dual antiplatelet therapy after percutaneous coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Kaiser Franz Josef Hospital | Conditions: Platelet Inhibition, Coronary Stent Implantation | Phase 3 | Status: COMPLETED | Results posted: 2013-05-01